Duloxetine on Opioid Consumption and Pain After Total Joint Arthroplasty: A Meta-Analysis .
Effect of duloxetine on opioid consumption and pain after total knee and hip arthroplasty: a systematic review and meta-analysis of randomized clinical trials.
Pain Med . 2023 Sep 1;24(9):1035-1045.Nine randomized controlled trials (806 patients) comparing the effect of duloxetine against a control in patients undergoing total hip or knee replacement (THA & TKA, respectively) were included in this systematic review and meta-analysis. Outcomes of interest included total opioid consumption, pain at rest and with activity on a Normalized Pain Scale (NPS), and the incidence of adverse events. Opioid consumption on days 2, 3, 7, and 14 favored the duloxetine group. Pain activity favored the duloxetine group at all time points except for 2 days and 6 weeks. Pain at rest favored the duloxetine group at 2, 3, 7, and 14 days with similar results at all other time points. All adverse events were similar among the two groups except for somnolence which favored the control group.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
